Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
ConditionAutoantibodies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKarolinska Institutet
About this trial
In this study, individuals with autoantibodies against Ro/SSA and La/SSB will be followed with regard to clinical manifestations and immunological parameters to identify immunological changes, environmental factors, and early clinical symptoms that characterize the progression from serological autoreactivity to clinically manifest disease.
Eligibility criteria
Qualifiers
None
Disqualifiers
Below 18 years of age
Inability to consent to their own participation
Ongoing infection or severe illness where the study physician deems participation in the study not to be in the individuals best interest
Inability to read and understand Swedish, and therefore unable to complete the forms and questionnaires included in the project
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov